Transactions
September 4 2025
TripleTree advises NEXT Oncology on its Acquisition by IQVIA
IQVIA (NYSE: IQV), a leading provider of clinical research services to the life sciences and healthcare industries, has acquired NEXT Oncology, a global network of clinical sites conducting community-based early-phase oncology clinical trials.
LEAD INVESTMENT BANKERS
Luke Mitchell
Michael Hughey
Colin Aldridge
IQVIA (NYSE: IQV), a leading provider of clinical research services to the life sciences and healthcare industries, has acquired NEXT Oncology, a global network of clinical sites conducting community-based early-phase oncology clinical trials.
LEAD INVESTMENT BANKERS
Luke Mitchell
Michael Hughey
Colin Aldridge
We prioritize your privacy. We do not sell your information and will only send occasional, relevant emails.
Copyright © 2025 TripleTree, LLC.
All Rights Reserved